Cargando…
Optimizing clinical guidelines to address antimicrobial-resistant infections: A conceptual framework reflecting stakeholder perspectives
OBJECTIVES: Clinical guidelines or guidance is an important tool for preventing and treating antimicrobial-resistant (AMR) infections. We sought to understand and support the effective use of guidelines and guidance for AMR infections. METHODS: Key informant interviews and a stakeholder meeting on t...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cambridge University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9972534/ https://www.ncbi.nlm.nih.gov/pubmed/36865700 http://dx.doi.org/10.1017/ash.2022.319 |
_version_ | 1784898345593995264 |
---|---|
author | Powell, Rhea E. Felt-Lisk, Sue Chen, Arnold Sullivan, Casey |
author_facet | Powell, Rhea E. Felt-Lisk, Sue Chen, Arnold Sullivan, Casey |
author_sort | Powell, Rhea E. |
collection | PubMed |
description | OBJECTIVES: Clinical guidelines or guidance is an important tool for preventing and treating antimicrobial-resistant (AMR) infections. We sought to understand and support the effective use of guidelines and guidance for AMR infections. METHODS: Key informant interviews and a stakeholder meeting on the development and use of guidelines and guidance for management of AMR infections; the interview findings and meeting discussion informed a conceptual framework for AMR infection clinical guidelines. PARTICIPANTS: Interview participants included experts with experience in guidelines development and physician and pharmacist hospital leaders and antibiotic stewardship program leaders. Stakeholder meeting participants included federal and nonfederal participants involved in research, policy, and practice related to prevention and management of AMR infections. RESULTS: Participants described challenges related to timeliness of guidelines, methodologic limitations of the development process, and issues with usability across a range of clinical settings. These findings, and participants’ suggestions for mitigating the challenges identified, informed a conceptual framework for AMR infection clinical guidelines. The framework components include (1) science and evidence, (2) guideline and guidance development and dissemination, and (3) implementation and real-world practice. These components are supported by engaged stakeholders whose leadership and resources help to improve patient and population AMR infection prevention and management. CONCLUSIONS: Use of guidelines and guidance documents for management of AMR infections can be supported through (1) a robust body of scientific evidence to inform guidelines and guidance; (2) approaches and tools to support timely, transparent guidelines that are relevant and actionable for all clinical audiences; and (3) tools to implement guidelines and guidance effectively. |
format | Online Article Text |
id | pubmed-9972534 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Cambridge University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-99725342023-03-01 Optimizing clinical guidelines to address antimicrobial-resistant infections: A conceptual framework reflecting stakeholder perspectives Powell, Rhea E. Felt-Lisk, Sue Chen, Arnold Sullivan, Casey Antimicrob Steward Healthc Epidemiol Original Article OBJECTIVES: Clinical guidelines or guidance is an important tool for preventing and treating antimicrobial-resistant (AMR) infections. We sought to understand and support the effective use of guidelines and guidance for AMR infections. METHODS: Key informant interviews and a stakeholder meeting on the development and use of guidelines and guidance for management of AMR infections; the interview findings and meeting discussion informed a conceptual framework for AMR infection clinical guidelines. PARTICIPANTS: Interview participants included experts with experience in guidelines development and physician and pharmacist hospital leaders and antibiotic stewardship program leaders. Stakeholder meeting participants included federal and nonfederal participants involved in research, policy, and practice related to prevention and management of AMR infections. RESULTS: Participants described challenges related to timeliness of guidelines, methodologic limitations of the development process, and issues with usability across a range of clinical settings. These findings, and participants’ suggestions for mitigating the challenges identified, informed a conceptual framework for AMR infection clinical guidelines. The framework components include (1) science and evidence, (2) guideline and guidance development and dissemination, and (3) implementation and real-world practice. These components are supported by engaged stakeholders whose leadership and resources help to improve patient and population AMR infection prevention and management. CONCLUSIONS: Use of guidelines and guidance documents for management of AMR infections can be supported through (1) a robust body of scientific evidence to inform guidelines and guidance; (2) approaches and tools to support timely, transparent guidelines that are relevant and actionable for all clinical audiences; and (3) tools to implement guidelines and guidance effectively. Cambridge University Press 2023-02-16 /pmc/articles/PMC9972534/ /pubmed/36865700 http://dx.doi.org/10.1017/ash.2022.319 Text en © The Author(s) 2023 This is a work of the US Government and is not subject to copyright protection within the United States. Published by Cambridge University Press on behalf of The Society for Healthcare Epidemiology of America. https://creativecommons.org/licenses/by/4.0/This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution and reproduction, provided the original article is properly cited. |
spellingShingle | Original Article Powell, Rhea E. Felt-Lisk, Sue Chen, Arnold Sullivan, Casey Optimizing clinical guidelines to address antimicrobial-resistant infections: A conceptual framework reflecting stakeholder perspectives |
title | Optimizing clinical guidelines to address antimicrobial-resistant infections: A conceptual framework reflecting stakeholder perspectives |
title_full | Optimizing clinical guidelines to address antimicrobial-resistant infections: A conceptual framework reflecting stakeholder perspectives |
title_fullStr | Optimizing clinical guidelines to address antimicrobial-resistant infections: A conceptual framework reflecting stakeholder perspectives |
title_full_unstemmed | Optimizing clinical guidelines to address antimicrobial-resistant infections: A conceptual framework reflecting stakeholder perspectives |
title_short | Optimizing clinical guidelines to address antimicrobial-resistant infections: A conceptual framework reflecting stakeholder perspectives |
title_sort | optimizing clinical guidelines to address antimicrobial-resistant infections: a conceptual framework reflecting stakeholder perspectives |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9972534/ https://www.ncbi.nlm.nih.gov/pubmed/36865700 http://dx.doi.org/10.1017/ash.2022.319 |
work_keys_str_mv | AT powellrheae optimizingclinicalguidelinestoaddressantimicrobialresistantinfectionsaconceptualframeworkreflectingstakeholderperspectives AT feltlisksue optimizingclinicalguidelinestoaddressantimicrobialresistantinfectionsaconceptualframeworkreflectingstakeholderperspectives AT chenarnold optimizingclinicalguidelinestoaddressantimicrobialresistantinfectionsaconceptualframeworkreflectingstakeholderperspectives AT sullivancasey optimizingclinicalguidelinestoaddressantimicrobialresistantinfectionsaconceptualframeworkreflectingstakeholderperspectives |